Financial Performance - Cabot Corporation (CBT) reported a net income of 1.67 per share for Q1 fiscal 2025, an increase from 0.88 per share in the same quarter last year [1] - Adjusted earnings per share (EPS) were 1.56 year-over-year, but below the Zacks Consensus Estimate of 955 million, missing the Zacks Consensus Estimate of 611 million, missing the Zacks Consensus Estimate of 1 million year-over-year, driven by volume growth and favorable pricing from customer agreements [3] - Performance Chemicals sales rose by 9.1% to 296.1 million, with EBIT growing by 183 million, with cash flows from operating activities amounting to 77 million, with 42 million for share repurchases during the quarter [5] Outlook - Cabot expects adjusted EPS for fiscal 2025 to be between 7.80, considering business segment results and customer agreements [6] - The outlook incorporates foreign exchange rates and interest rate projections but excludes potential tariff impacts, with strong operating cash flow anticipated to support growth investments and shareholder returns [6] - The company is focused on its "Creating for Tomorrow" strategy aimed at long-term value creation [6] Stock Performance - CBT stock has increased by 19.3% over the past year, outperforming the industry growth of 5% [7]
Cabot's Earnings and Revenues Lag Estimates in Q1, EPS Up Y/Y